• China Shineway Pharmaceutical Group's board comprises seven directors, with four board committees, effective Nov. 1, 2026.
• Executive directors are Li Zhenjiang, Li Huimin and Kang Limin. Li Zhenjiang chairs the nomination committee.
• Independent non-executive directors are Liu Shun Fai, Yew Yat On and Wang Guihua.
• Zhou Wencheng serves as non-executive director. Wang Guihua chairs the remuneration committee.
• Liu Shun Fai chairs the audit committee and the corporate social responsibility and sustainability committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Shineway Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12389411), on October 30, 2026, and is solely responsible for the information contained therein.